Skip to main content

‘Self-Driving’ Microscope Predicts Neurodegenerative Disease






The accumulation of misfolded proteins in the brain is central to the progression of neurodegenerative diseases such as Huntington’s, Alzheimer’s, and Parkinson’s. But to the human eye, proteins that are destined to form harmful aggregates are indistinguishable from normal proteins. The formation of such aggregates also tends to happen randomly and relatively rapidly — on the scale of minutes. The ability to identify and characterize protein aggregates is essential for understanding and fighting neurodegenerative diseases.

Now, using deep learning, École Polytechnique Fédérale de Lausanne (EPFL) researchers have developed a “self-driving” imaging system that leverages multiple microscopy methods to track and analyze protein aggregation in real time — and even anticipate it before it begins. In addition to maximizing imaging efficiency, the approach minimizes the use of fluorescent labels, which can alter the biophysical properties of cell samples and impede accurate analysis.

“This is the first time we have been able to accurately foresee the formation of these protein aggregates,” said recent EPFL Ph.D. graduate Khalid Ibrahim. “Because their biomechanical properties are linked to diseases and the disruption of cellular function, understanding how these properties evolve throughout the aggregation process will lead to fundamental understanding essential for developing solutions.”

The project is the result of a longstanding collaboration between the labs of Aleksandra Radenovic, head of the Laboratory of Nanoscale Biology and Hilal Lashuel of the school of sciences. The work unites complementary expertise in neurodegeneration and advanced live-cell imaging technologies.

“This project was born out of a motivation to build methods that reveal new biophysical insights, and it is exciting to see how this vision has now borne fruit,” Radenovic said.

In their first collaborative effort, led by Ibrahim, the team developed a deep learning algorithm that was able to detect mature protein aggregates when presented with unlabeled images of living cells. The new study builds on that work with an image classification version of the algorithm that analyzes such images in real time: when this algorithm detects a mature protein aggregate, it triggers a Brillouin microscope, which analyzes scattered light to characterize the aggregates’ biomechanical properties like elasticity.

Normally, the slow imaging speed of a Brillouin microscope would make it a poor choice for studying rapidly evolving protein aggregates. But thanks to the EPFL team’s AI-driven approach, the Brillouin microscope is only switched on when a protein aggregate is detected, speeding up the entire process while opening new avenues in smart microscopy.

“This is the first publication that shows the impressive potential for self-driving systems to incorporate label-free microscopy methods, which should allow more biologists to adopt rapidly evolving smart microscopy techniques,” Ibrahim said.

Because the image classification algorithm only targets mature protein aggregates, the researchers still needed to go further if they wanted to catch aggregate formation in the act. For this, they developed a second deep learning algorithm and trained it on fluorescently labelled images of proteins in living cells. This “aggregation-onset” detection algorithm can differentiate between near-identical images to correctly identify when aggregation will occur with 91% accuracy. Once this onset is spotted, the self-driving system again switches on Brillouin imaging to provide a never-before-seen window into protein aggregation. For the first time, the biomechanics of this process can be captured dynamically as it occurs.

Lashuel emphasized that in addition to advancing smart microscopy, this work has important implications for drug discovery and precision medicine. “Label-free imaging approaches create entirely new ways to study and target small protein aggregates called toxic oligomers, which are thought to play central causative roles in neurodegeneration,” he said. “We are excited to build on these achievements and pave the way for drug development platforms that will accelerate more effective therapies for neurodegenerative diseases.”

Bio Photonics Research Award


Visit: biophotonicsresearch.com
Nominate Now: https://biophotonicsresearch.com/award-nomination/?ecategory=Awards&rcategory=Awardee

#MeatAnalysis #FluorescenceTech #FoodQuality #FoodSafety #SpectroscopyInFood #MeatAuthentication #RapidDetection #FoodScience #MeatFreshness #MolecularDetection #FoodIndustryInnovation #NonDestructiveTesting #FoodMonitoring #SpectroscopyApplications #QualityControl #AdvancedSpectroscopy #MeatSpoilageDetection #FoodIntegrity #SmartFoodTesting #RealTimeAnalysis #FoodAuthenticity #FoodSafetyInnovation #SpectroscopyResearch #NextGenFoodSafety #InnovativeFoodScience,

Comments

Popular posts from this blog

Abrisa Technologies Acquires Agama Glass Technologies

SANTA PAULA, Calif. — Abrisa Technologies, a provider of custom glass optics and thin film coatings and a subsidiary of HEF Photonics, has acquired Agama Glass Technologies, a manufacturer of etched anti-glare glass and technical glass processing. The acquisition, Abrisa said, expands its manufacturing footprint and adds a vertically integrated solution for chemically etched anti-glare display glass. According to Abrisa, Clarksburg, West Virginia-based Agama operates North America’s only high-volume technical glass etching facility. Agama's flagship product, AgamaEtch, is used in high-performance display and optics applications. The company's 85,000 sq ft facility also offers precision glass fabrication, chemical strengthening, and silk-screen printing, serving markets such as avionics, defense, medical, industrial, and touchscreen displays. Combined with Abrisa Technologies’ and HEF Photonics’ thin-film coating and surface engineering capabilities, Agama's offerings wi...

How Biophotonics Is Harnessing Light for Health And Science

Fifty or so years ago French physicist Pierre Aigrain coined the term photonics as a research field whose goal was to use light to perform functions that traditionally fell within the typical domain of electronics, such as telecommunications, and information processing. Or maybe it was John Campbell who, in a letter sent to Gotthard Gunther in 1954, wrote, “Incidentally, I’ve decided to invent a new science — photonics. It bears the same relationship to Optics that electronics does to electrical engineering. Photonics, like electronics, will deal with the individual units; optics and EE deal with the group phenomena! And note that you can do things with electronics that are impossible in electrical engineering!” Naming rights aside, the field of photonics began in earnest between 1958 and 1960 with the invention of the maser and the laser. The laser diode followed during the 1970s, optical fibers and the erbium-doped fiber amplifier after that, and, pretty soon, the telecommunications...

Accurate Magnetic Field Measurement Method Could Advance Quantum Sensing

  Optically pumped magnetometers (OPMs) are used to measure magnetic fields in biosensing, contraband testing, and magnetic communications. They also aid in dark matter searches and serve as promising platforms for quantum -enhanced measurements. Accurate vector magnetometry, however, remains a challenge for OPMs due to the OPM’s inherent scalar operation. Scalar OPMs require an external reference to extract directional information. While scalar measurements are often sufficient, robust calibration of vector OPMs is increasingly important for applications requiring high accuracy as well as precision. Researchers at JILA, a joint research institute of the University of Colorado Boulder and the National Institute of Standards and Technology, demonstrated a vector OPM that uses Rabi oscillations driven between the manifolds of rubidium atoms to measure the direction of a magnetic field against the polarization ellipse structure of a microwave field. The researchers exposed a cell con...